Stefan Blankenberg

Author PubWeight™ 265.08‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genomewide association analysis of coronary artery disease. N Engl J Med 2007 24.38
2 Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 2011 13.25
3 Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 2012 12.10
4 Genetics and beyond--the transcriptome of human monocytes and disease susceptibility. PLoS One 2010 7.48
5 Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009 6.62
6 New loci associated with kidney function and chronic kidney disease. Nat Genet 2010 5.58
7 Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet 2011 5.26
8 Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation 2008 5.20
9 New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet 2009 5.12
10 Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Nat Genet 2009 3.81
11 Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 2002 3.20
12 Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: A Genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controls. Circ Cardiovasc Genet 2010 3.15
13 Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation 2005 3.02
14 A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk. Nature 2010 2.88
15 Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 2011 2.61
16 Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators. Blood 2009 2.27
17 Genetically determined height and coronary artery disease. N Engl J Med 2015 2.24
18 Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study. Circ Res 2005 2.24
19 Different calculations of ankle-brachial index and their impact on cardiovascular risk prediction. Circulation 2008 2.20
20 Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. Clin Chem 2011 2.14
21 Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data. JAMA 2009 2.10
22 CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels. Thromb Haemost 2004 2.09
23 Comparison of a 3-hour versus a 6-hour sampling-protocol using high-sensitivity cardiac troponin T for rule-out and rule-in of non-STEMI in an unselected emergency department population. Int J Cardiol 2012 2.02
24 Severe intraprocedural complications after transcatheter aortic valve implantation: calling for a heart team approach. Eur J Cardiothorac Surg 2013 2.01
25 How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J 2012 2.00
26 Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction. Circulation 2011 1.96
27 Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque. Nat Genet 2011 1.92
28 High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort. Eur Heart J 2013 1.85
29 Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study. Eur Heart J 2008 1.82
30 Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study. Circ Cardiovasc Genet 2009 1.81
31 Multiple marker approach to risk stratification in patients with stable coronary artery disease. Eur Heart J 2010 1.80
32 Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol 2010 1.75
33 A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur Heart J 2011 1.67
34 Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care 2010 1.66
35 Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene study. Eur Heart J 2005 1.65
36 A genome-wide association study identifies LIPA as a susceptibility gene for coronary artery disease. Circ Cardiovasc Genet 2011 1.63
37 Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study. Eur Heart J 2004 1.58
38 Predictors and outcomes after transcatheter aortic valve implantation using different approaches according to the valve academic research consortium definitions. Catheter Cardiovasc Interv 2013 1.58
39 The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study. Eur Heart J 2008 1.57
40 C4BPB/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S-independent mechanism: results from genome-wide association and gene expression analyses followed by case-control studies. Blood 2010 1.54
41 Thirty-one novel biomarkers as predictors for clinically incident diabetes. PLoS One 2010 1.53
42 Association of serum procalcitonin with cardiovascular prognosis in coronary artery disease. Circ J 2011 1.52
43 Noninvasive vascular function measurement in the community: cross-sectional relations and comparison of methods. Circ Cardiovasc Imaging 2011 1.52
44 High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality. Eur Heart J 2013 1.46
45 The inflammatory hypothesis: any progress in risk stratification and therapeutic targets? Circulation 2006 1.45
46 Integrating genome-wide genetic variations and monocyte expression data reveals trans-regulated gene modules in humans. PLoS Genet 2011 1.40
47 Somatic symptoms in patients with coronary heart disease: prevalence, risk factors, and quality of life. JAMA Intern Med 2013 1.40
48 Impact of infectious burden on progression of carotid atherosclerosis. Stroke 2002 1.40
49 Kidney injury and mortality after transcatheter aortic valve implantation in a routine clinical cohort. Catheter Cardiovasc Interv 2014 1.39
50 Transseptal and transmitral Parachute® implantation in conjunction with "MitraClipping". EuroIntervention 2015 1.38
51 Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines. Am J Cardiol 2003 1.34
52 Analyzing illumina gene expression microarray data from different tissues: methodological aspects of data analysis in the metaxpress consortium. PLoS One 2012 1.31
53 Discovery and fine mapping of serum protein loci through transethnic meta-analysis. Am J Hum Genet 2012 1.29
54 Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies. Circ Cardiovasc Genet 2011 1.26
55 Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2007 1.22
56 Statistical colocalization of monocyte gene expression and genetic risk variants for type 1 diabetes. Hum Mol Genet 2012 1.20
57 Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease. Nutr Metab (Lond) 2006 1.20
58 The relation of genetic and environmental factors to systemic inflammatory biomarker concentrations. Circ Cardiovasc Genet 2009 1.19
59 Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application. Clin Res Cardiol 2013 1.16
60 Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 2002 1.15
61 High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease. Arterioscler Thromb Vasc Biol 2003 1.13
62 Glutathione peroxidase-1 activity, atherosclerotic burden, and cardiovascular prognosis. Am J Cardiol 2007 1.12
63 Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease. Hum Mol Genet 2004 1.08
64 Oxidative stress in cardiovascular disease: successful translation from bench to bedside? Circulation 2007 1.07
65 Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: results from the AtheroGene study. J Am Coll Cardiol 2005 1.05
66 Effects of oral niacin on endothelial dysfunction in patients with coronary artery disease: results of the randomized, double-blind, placebo-controlled INEF study. Atherosclerosis 2008 1.04
67 Development of a risk score for outcome after transcatheter aortic valve implantation. Clin Res Cardiol 2014 1.04
68 Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study. Eur Heart J 2009 1.04
69 Genome-wide haplotype analysis of cis expression quantitative trait loci in monocytes. PLoS Genet 2013 1.03
70 Genomewide association studies in cardiovascular disease--an update 2011. Clin Chem 2011 1.03
71 Resistin, acute coronary syndrome and prognosis results from the AtheroGene study. Atherosclerosis 2006 1.03
72 GUESS-ing polygenic associations with multiple phenotypes using a GPU-based evolutionary stochastic search algorithm. PLoS Genet 2013 1.03
73 Edwards Sapien XT valve placement as treatment option for aortic regurgitation after transfemoral CoreValve implantation: a multicenter experience. Clin Res Cardiol 2013 1.03
74 Bayesian detection of expression quantitative trait loci hot spots. Genetics 2011 1.00
75 Transcatheter mitral valve-in-valve implantation in patients with degenerated bioprostheses. JACC Cardiovasc Interv 2012 1.00
76 Impact of metabolic syndrome on atherosclerotic burden and cardiovascular prognosis. Am J Cardiol 2007 0.99
77 B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study. J Am Coll Cardiol 2006 0.99
78 Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 2002 0.99
79 Distribution and categorization of left ventricular measurements in the general population: results from the population-based Gutenberg Heart Study. Circ Cardiovasc Imaging 2010 0.98
80 Sex differences in early carotid atherosclerosis (from the community-based Gutenberg-Heart Study). Am J Cardiol 2011 0.98
81 A follow-up study of a genome-wide association scan identifies a susceptibility locus for venous thrombosis on chromosome 6p24.1. Am J Hum Genet 2010 0.98
82 Atrial fibrillation: its prevalence and risk factor profile in the German general population. Dtsch Arztebl Int 2012 0.97
83 The molecular genetic architecture of self-employment. PLoS One 2013 0.96
84 Improved outcome in acute coronary syndrome by establishing a chest pain unit. Clin Res Cardiol 2009 0.96
85 Inflammatory markers and cardiovascular risk in the metabolic syndrome. Front Biosci (Landmark Ed) 2011 0.95
86 Cardiac fibroblasts support cardiac inflammation in heart failure. Basic Res Cardiol 2014 0.95
87 Differential haplotypic expression of the interleukin-18 gene. Eur J Hum Genet 2007 0.94
88 Pathogenic cycle between the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine and the leukocyte-derived hemoprotein myeloperoxidase. Circulation 2011 0.93
89 Inflammation, atherosclerotic burden and cardiovascular prognosis. Atherosclerosis 2007 0.92
90 Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study. Eur Heart J 2006 0.92
91 Surgical or percutaneous mitral valve repair for secondary mitral regurgitation: comparison of patient characteristics and clinical outcomes. Eur J Cardiothorac Surg 2013 0.91
92 Influence of sex and genetic variability on expression of X-linked genes in human monocytes. Genomics 2011 0.91
93 Prevalence of distress, comorbid conditions and well being in the general population. J Affect Disord 2010 0.91
94 The validity of heart failure diagnoses obtained from administrative registers. Eur J Prev Cardiol 2012 0.90
95 Defining a reference population to determine the 99th percentile of a contemporary sensitive cardiac troponin I assay. Int J Cardiol 2012 0.90
96 Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study. J Am Heart Assoc 2013 0.89
97 Type-D personality and depersonalization are associated with suicidal ideation in the German general population aged 35-74: results from the Gutenberg Heart Study. J Affect Disord 2010 0.89
98 Activation of polymorphonuclear neutrophils in patients with impaired left ventricular function. Free Radic Biol Med 2007 0.89
99 Association of multiple biomarkers and classical risk factors with early carotid atherosclerosis: results from the Gutenberg Health Study. Clin Res Cardiol 2014 0.89
100 Serum sphingomyelin levels are related to the clearance of postprandial remnant-like particles. J Lipid Res 2004 0.89
101 Impact of inflammatory markers on cardiovascular mortality in patients with metabolic syndrome. Eur J Cardiovasc Prev Rehabil 2008 0.88
102 Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease The SElenium Therapy in Coronary Artery disease Patients (SETCAP) Study. Am Heart J 2008 0.88
103 Diagnosing heart failure with preserved ejection fraction. Expert Opin Med Diagn 2013 0.88
104 Hazardous alcohol consumption is associated with increased levels of B-type natriuretic peptide: evidence from two population-based studies. Eur J Epidemiol 2013 0.88
105 Blood-based gene expression tests: promises and limitations. Circ Cardiovasc Genet 2013 0.87
106 Homoarginine levels are regulated by L-arginine:glycine amidinotransferase and affect stroke outcome: results from human and murine studies. Circulation 2013 0.87
107 PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGene study. J Lipid Res 2008 0.87
108 Monocyte-derived dendritic cells of patients with coronary artery disease show an increased expression of costimulatory molecules CD40, CD80 and CD86 in vitro. Coron Artery Dis 2007 0.87
109 The choice of the filtering method in microarrays affects the inference regarding dosage compensation of the active X-chromosome. PLoS One 2011 0.87
110 Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia. Hum Mol Genet 2013 0.86
111 Transapical implantation of a second-generation transcatheter heart valve in patients with noncalcified aortic regurgitation. JACC Cardiovasc Interv 2013 0.86
112 High-sensitivity cardiac troponin I in the general population--defining reference populations for the determination of the 99th percentile in the Gutenberg Health Study. Clin Chem Lab Med 2015 0.86
113 Transfemoral TAVI without pre-dilatation using balloon-expandable devices: a case-matched analysis. Clin Res Cardiol 2015 0.86
114 Lack of association between complement factor H polymorphisms and coronary artery disease or myocardial infarction. J Mol Med (Berl) 2007 0.85
115 Blood transfusion is associated with impaired outcome after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2014 0.85
116 Annexin V does not represent a diagnostic alternative to myoglobin for early detection of myocardial infarction. Clin Lab 2002 0.85
117 Serum selenium and prognosis in cardiovascular disease: results from the AtheroGene study. Atherosclerosis 2009 0.85
118 Total serum transforming growth factor-β1 is elevated in the entire spectrum of genetic aortic syndromes. Clin Cardiol 2014 0.85
119 BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries. Eur J Epidemiol 2014 0.85
120 Sex differences in noninvasive vascular function in the community. J Hypertens 2013 0.84
121 Lack of association of genetic variants in the LRP8 gene with familial and sporadic myocardial infarction. J Mol Med (Berl) 2008 0.84
122 Genome-wide association study of L-arginine and dimethylarginines reveals novel metabolic pathway for symmetric dimethylarginine. Circ Cardiovasc Genet 2014 0.83
123 Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease. Arterioscler Thromb Vasc Biol 2013 0.83
124 Systems Genetics Analysis of Genome-Wide Association Study Reveals Novel Associations Between Key Biological Processes and Coronary Artery Disease. Arterioscler Thromb Vasc Biol 2015 0.83
125 MR-proANP and MR-proADM for risk stratification of patients with acute chest pain. Heart 2012 0.82
126 Herpesvirus DNA (Epstein-Barr virus, herpes simplex virus, cytomegalovirus) in circulating monocytes of patients with coronary artery disease. Acta Cardiol 2005 0.82
127 Genetic variation of the interleukin-1 family and nongenetic factors determining the interleukin-1 receptor antagonist phenotypes. Metabolism 2010 0.82
128 Phospholipid transfer protein in hemodialysis patients. Am J Nephrol 2007 0.82
129 Direct measurement of left ventricular outflow tract by transthoracic real-time 3D-echocardiography increases accuracy in assessment of aortic valve stenosis. Int J Cardiol 2008 0.82
130 Reducing radiation exposure during invasive coronary angiography and percutaneous coronary interventions implementing a simple four-step protocol. Clin Res Cardiol 2015 0.81
131 Analytically false or true positive elevations of high sensitivity cardiac troponin: a systematic approach. Heart 2013 0.81
132 Aetiology of mitral regurgitation differentially affects 2-year adverse outcomes after MitraClip therapy in high-risk patients. Eur J Heart Fail 2013 0.81
133 Current treatment of heart failure with preserved ejection fraction: should we add life to the remaining years or add years to the remaining life? Cardiol Res Pract 2013 0.81
134 Association of high-sensitivity assayed troponin I with cardiovascular phenotypes in the general population: the population-based Gutenberg health study. Clin Res Cardiol 2013 0.81
135 Influence of HMG-CoA reductase inhibitors on markers of coagulation, systemic inflammation and soluble cell adhesion. Int J Cardiol 2002 0.81
136 Association of soluble endothelial protein C receptor plasma levels and PROCR rs867186 with cardiovascular risk factors and cardiovascular events in coronary artery disease patients: the Athero Gene study. BMC Med Genet 2012 0.81
137 Association of classical and related inflammatory markers with high-sensitivity C-reactive protein in healthy individuals: results from the Stanislas cohort. Clin Chem Lab Med 2007 0.80
138 Predictive value of midregional pro-adrenomedullin compared to natriuretic peptides for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort. Ann Med 2014 0.80
139 Is heme oxygenase-1 a causal player for plaque stability? Stroke 2005 0.80
140 Comprehensive exploration of the effects of miRNA SNPs on monocyte gene expression. PLoS One 2012 0.80
141 Making it more sensitive: the new era of troponin use. Circulation 2011 0.80
142 [Manifestations of atherosclerosis in various vascular regions. Similarities and differences regarding epidemiology, etiology and prognosis]. Med Klin (Munich) 2002 0.80
143 Valve-in-valve implantation of a novel and small self-expandable transcatheter heart valve in degenerated small surgical bioprostheses: the Hamburg experience. Catheter Cardiovasc Interv 2014 0.79
144 Cardiac mechanics in heart transplant recipients with and without transplant vasculopathy. Int J Cardiovasc Imaging 2015 0.79
145 Multiple endothelial biomarkers and noninvasive vascular function in the general population: the Gutenberg Health Study. Hypertension 2012 0.79
146 The Predictive Value of Depressive Symptoms for All-Cause Mortality: Findings From the PRIME Belfast Study Examining the Role of Inflammation and Cardiovascular Risk Markers. Psychosom Med 2016 0.79
147 Antiphospholipid antibodies in a large population-based cohort: genome-wide associations and effects on monocyte gene expression. Thromb Haemost 2016 0.78
148 Reference intervals of plasma homoarginine from the German Gutenberg Health Study. Clin Chem Lab Med 2016 0.78
149 Carcinoid Heart Valve Disease: Transcatheter Pulmonary Valve-In-Valve Implantation in Failing Biological Xenografts. J Heart Valve Dis 2015 0.78
150 Diagnostic and prognostic performance of myeloperoxidase plasma levels compared with sensitive troponins in patients admitted with acute onset chest pain. Circ Cardiovasc Genet 2012 0.78
151 Molecular and functional characterization of polymorphisms in the secreted phospholipase A2 group X gene: relevance to coronary artery disease. J Mol Med (Berl) 2009 0.78
152 Molecular Characterization of the NLRC4 Expression in Relation to Interleukin-18 Levels. Circ Cardiovasc Genet 2015 0.78
153 Adaptive linear rank tests for eQTL studies. Stat Med 2012 0.78
154 Human formyl peptide receptor 1 (FPR1) c.32C>T SNP is associated with decreased soluble E-selectin levels. Pharmacogenomics 2009 0.78
155 The best of both worlds: staged hybrid approach to complex cardiac disease in a patient at high surgical risk. Thorac Cardiovasc Surg 2012 0.78
156 Cholesteryl ester transfer protein activity and cardiovascular events in patients with chronic kidney disease stage V. Nephrol Dial Transplant 2008 0.78
157 Prognostic value of lipoproteins and their relation to inflammatory markers among patients with coronary artery disease. Int J Cardiol 2005 0.78
158 Graphical modeling of gene expression in monocytes suggests molecular mechanisms explaining increased atherosclerosis in smokers. PLoS One 2013 0.78
159 Towards an integrated approach to mitral valve disease: implementation of an interventional mitral valve programme and its impact on surgical activity. Eur J Cardiothorac Surg 2013 0.77
160 Midregional proadrenomedullin for prediction of cardiovascular events in coronary artery disease: results from the AtheroGene study. Clin Chem 2011 0.77
161 A multiple biomarker risk score for guiding clinical decisions using a decision curve approach. Eur J Prev Cardiol 2011 0.77
162 Association of MR-proadrenomedullin with cardiovascular risk factors and subclinical cardiovascular disease. Atherosclerosis 2013 0.76
163 Up-and-coming markers: myeloperoxidase, a novel biomarker test for heart failure and acute coronary syndrome application? Congest Heart Fail 2008 0.76
164 Bivalvular transcatheter treatment of high-surgical-risk patients with coexisting severe aortic stenosis and significant mitral regurgitation. Int J Cardiol 2012 0.76
165 Candidate biomarkers in heart failure with reduced and preserved ejection fraction. Biomarkers 2015 0.76
166 Midregional pro-atrial natriuretic peptide in the general population/Insights from the Gutenberg Health Study. Clin Chem Lab Med 2013 0.75
167 Reply: the latest generation of troponin immunoassays: the "cholesterol" of the third millennium? J Am Coll Cardiol 2014 0.75
168 Dimethylarginine dimethylaminohydrolase1 is an organ-specific mediator of end organ damage in a murine model of hypertension. PLoS One 2012 0.75
169 Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function. J Clin Invest 2017 0.75
170 Commentary: Circulating cytokines and risk stratification of stroke incidence--will we do better in future? Int J Epidemiol 2008 0.75
171 Depression in atrial fibrillation in the general population. PLoS One 2013 0.75
172 Is there a male-specific effect on hypertension? Hum Genet 2015 0.75
173 Atherosclerosis, oxidative stress and glutathione peroxidase-1: a new kid on the block. Ital Heart J 2004 0.75
174 Correction of acquired von Willebrand syndrome by transcatheter aortic valve implantation. J Invasive Cardiol 2014 0.75
175 Prognostic information of glycogen phosphorylase isoenzyme BB in patients with suspected acute coronary syndrome. Am J Cardiol 2012 0.75
176 Thirty-day VARC-2 and performance data of a new self-expanding transcatheter aortic heart valve. EuroIntervention 2015 0.75
177 Aspirin Before Elective Surgery-Stop or Continue? Dtsch Arztebl Int 2017 0.75
178 [Modern therapy in acute coronary syndrome]. Med Klin (Munich) 2002 0.75
179 The challenge of valve-in-valve procedures in degenerated Mitroflow bioprostheses and the advantage of using the JenaValve transcatheter heart valve. EuroIntervention 2014 0.75
180 Impact of biomarkers, proteomics, and genomics in cardiovascular disease. Clin Chem 2011 0.75
181 First-in-man treatment of a degenerated mitral surgical valve with the mechanical expanding Lotus™ valve. EuroIntervention 2016 0.75
182 Radiation exposure during the implantation of bioabsorbable vascular scaffolds versus drug-eluting stents in non-complex coronary lesions: a matched-cohort study. Minerva Cardioangiol 2016 0.75
183 Baseline systolic left ventricular function determines hemodynamic adaptation following percutaneous mitral valve repair. Int J Cardiol 2012 0.75